Skip to main content

Table 4 Expression level of hsa-miR-4638-3p and hsa-miR-1273 g-3p in the peripheral blood of each group (Log2∆Ct value)

From: Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity

  

Mean value (X ± SD)

Group

N

hsa-miR-4638-3p

hsa-miR-1273 g-3p

A

20

1.29 ± 0.72

1.00 ± 0.20

C

20

2.66 ± 1.38*

0.48 ± 0.17*

  

P = 0.000

P = 0.000

  1. Note: paired t test was adopted: *P < 0.05. Group A: anthraycline based chemotherapy induced cardiotoxicity; group C:breast cancer patients ejection fraction before starting chemotherapy
  2. SD Standard Deviation, X sample mean
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us